{"id":"W3182533416","doi":"10.1080/10428194.2021.1938027","title":"A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies","year":2021,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Cancer research; Pharmacodynamics; Pharmacology; Internal medicine; Oncology; Lymphoma; Pharmacokinetics; Tyrosine kinase; Chronic lymphocytic leukemia; Biology; Leukemia; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004543498,0.0004962094,0.001066701,0.0003051952,0.0001755716,0.00004576887,0.0003138121,0.0003233191,0.00003077672],"category_scores_gemma":[0.0003162496,0.0003627424,0.0001266802,0.001194042,0.000617711,0.0002515074,0.000450784,0.0002117012,0.000003471447],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01300839,"about_ca_system_score_gemma":0.0140658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001960225,"about_ca_topic_score_gemma":0.000222232,"domain_scores_codex":[0.9958028,0.0003274247,0.001071776,0.0008577151,0.001294642,0.000645694],"domain_scores_gemma":[0.9971139,0.0004091499,0.000504186,0.001097368,0.000596655,0.0002787023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01662153,0.03990842,0.8213907,0.004010377,0.0008834977,0.001136713,0.01976245,0.00007434285,0.02243692,0.000977971,0.0008293364,0.07196774],"study_design_scores_gemma":[0.3106194,0.004878542,0.6559516,0.0007895312,0.0003278971,0.0001898405,0.003190099,0.001909568,0.02120044,0.00007739318,0.0004403905,0.0004253137],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961373,0.0009132161,0.000005377185,0.0000480492,0.0001200882,0.001384098,0.00002897159,0.00003781167,0.001325047],"genre_scores_gemma":[0.9986378,0.0001950918,0.0001604233,0.0001711046,0.00002844531,0.00006841647,0.00004540842,0.00007755945,0.0006157621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2939978,"threshold_uncertainty_score":0.9998825,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00943998338930477,"score_gpt":0.2521259848472878,"score_spread":0.2426860014579831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}